Today on DrugResearcher.com
 
Stem cell breakthrough avoids the embryo controversy

Icahn invests in Genzyme, prompts takeover rumours

Targeted lupus treatment on the horizon

Preclinical services news in brief

Drugs moving into the clinic: 35

 
   
Related Industry News
 
Extra breathing space for epinephrine MDI ban

AMRI continues growth

PRA's profits will soon be private

BioCryst clinical trials debacle highlights protocol perils

 
 

Drug discovery

Breaking News on Drug Discovery
Daily  Thursday 15 November 2007 Forward to a colleague

Product Presentation

SequantZIC®-HILIC Separation of Polar and Hydrophilic Compounds

The technology leading ZIC®HILIC and ZIC®-pHILIC separation media, designed for polar and hydrophilic compounds, are tools for clinical analysis and to solve separation and purification problems in research, development and production of pharmaceuticals. ZIC®-HILIC... Click Here

Access Full Stories



Stem cell breakthrough avoids the embryo controversy
US researchers have developed a way of creating primate embryonic stem cells that avoids the need to use fertilised embryos, potentially leading to more ethical ways of curing degenerative diseases... Read


Icahn invests in Genzyme, prompts takeover rumours
The man often credited with causing Biogen Idec to be put up for sale, billionaire corporate raider Carl Icahn, has invested in Genzyme and promptly started industry tongues wagging about a takeover... Read


Targeted lupus treatment on the horizon
Researchers have uncovered some of the underlying causes of lupus, and have even suggested certain targeted therapies to tackle the autoimmune disease... Read


Preclinical services news in brief
In this week's review of activity within the preclinical research services arena, news has emerged involving GATC Biotech, NextGen Sciences and Genedata... Read


Drugs moving into the clinic: 35
The latest in a series of periodic roundups of drugs that have moved from preclinical research into clinical testing via the announcement of a Phase I trial or an application for a trial to industry regulators... Read


All News Headlines for:
November | October | September

Fully autoclavable and Universal tip fittingSponsored Link

CappAero pipettes - ultimate accuracy and intelligent design

The cool transparent handle and dash of vibrant colour on the barrel ensures the ColorLine series will be a welcome addition to any laboratory. The distinctive colour of each pipette permits you to quickly identify the volume range of any pipette at a glance... Click Here

Related Industry News



Extra breathing space for epinephrine MDI ban
The US Food and Drug Administration (FDA) has given stakeholders an extra month to get their views in on scrapping epinephrine inhalers containing CFCs... Read


AMRI continues growth
Albany Molecular Research Inc (AMRI) recently turned in Q3 results, posting figures buoyed by continued demand for its pharmaceutical development services... Read


PRA's profits will soon be private
PRA International continues to see its profits ebb away but will soon face less financial scrutiny as it nears a handover of ownership into private hands. ... Read


BioCryst clinical trials debacle highlights protocol perils
BioCryst's recent clinical trials debacle highlights the importance of the robust and realistic design of, and careful adherence to, a drug trial protocol... Read


Weekly Comment

Pharma must 'reinvent' itself to survive

With IMS Health's annual forecast for the pharma industry predicting slower approvals, more black box warnings and the continuation of the 'wave of genericization,' the shift by pharma firms to refocus and reinvent themselves will need to move on apace in order to secure their position in a changing market. Read



SMI Anti-Arthritic ConferenceSponsored Link

7th Annual Anti-Arthritic Agents Conference

Examine the latest developments in the research of therapeutics for Arthritic and Inflammatory indications, and listen to case studies from the leading companies in the field. 19th & 20th November 2007, Hesperia Victoria Hotel, UK... Click Here
Previous Headlines



Evotec's metamorphosis erodes profit
Evotec's bid to distance itself from being a services business and eventually morph into a fully fledged pharma company has been felt on the company's balance sheet during the third quarter... Read


Accelrys offers academics its scientific operating system for free
Accelrys is offering its SciTegic scientific operating system to academics for free to enable them to create software applications and share them with both academic and commercial communities... Read


Ventana reluctantly opens up to Roche in a bid to boost offer
In the latest twist in Roche's fight to acquire diagnostics expert Ventana, the companies have signed a confidentiality agreement that will enable the pharma giant access to Ventana's books... Read


AstraZeneca in 'serious trouble', say analysts
An analyst report released yesterday identified AstraZeneca as being in 'serious trouble' and branded it as potentially the 'worst [large cap] performer in [the] entire sector' over the next eight years... Read


Applied Biosystems and BioTrove form HT genotyping alliance
Applied Biosystems and BioTrove have signed a licensing and collaboration agreement to commercialise an analysis platform for high-throughput (HT) genotyping applications... Read

Technical / White Papers, Case studies, Web casts
Benefits of integrating human tissue research in drug discovery - Technical / White Paper

Manufacturing Variations in Polysorbate Batches - Technical / White Paper



Product Information - brochures, Web centers
ZIC®-HILIC Separation of Polar and Hydrophilic Compounds - Product Presentation

DAICEL chiral chromatography products - Company Profile

Rapid HPLC method development with ChromSword®Auto software - Product Presentation

Separation of polar compounds - Application Notes



Product Innovation Alerts - Free of Charge
Indicate your research interests and receive alerts on relevant products and market innovations
Analysis and instrumentation
Assays and screening
Cell culture & Equipment
Chromatography
Compounds and consumables
Contract services (outsourcing)
Drug discovery
Genomics / Proteomics
Informatics & IT
Lab equipment & consumables
Liquid handling and automation
Liquid handling and sample preparation
Production technologies
Separation and purification




Free Newsletters for Pharmaceuticals
Access now !Choose from over 20 industry e-newsletters
Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here

Forward to a colleague

To continue to receive this newsletter in your inbox, please add
newsletter@DrugResearcher.com to your address book

Update preferences | Change your email address | Unsubscribe

Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback

© 2007 - Decision News Media S.A.S - All Rights Reserved
Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France
http://www.decisionnewsmedia.com